CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in AKBA — Akebia Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in AKBA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,622,499
-$179,153 QoQ
Shares Held
2,300,438
+14.1% QoQ
Ownership
0.830%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 170 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AKBA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $1,705,244,386 across 43 Drug Manufacturers - Specialty & Generic names. AKBA ranks #34 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
4,003,981 | $287,726,073 | |
| 2 | VTRS |
Viatris Inc
|
13,567,342 | $215,449,390 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
974,279 | $164,204,982 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
297,162 | $161,011,285 | |
| 5 | ALKS |
Alkermes plc.
|
2,335,117 | $122,360,130 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
3,553,213 | $87,444,571 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
2,453,787 | $85,072,795 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
665,457 | $73,825,799 |
All Filings in AKBA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,622,499 | 2,300,438 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,801,652 | 2,015,577 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,511,120 | 2,180,820 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,924,867 | 2,170,281 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,726,414 | 749,015 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,195,994 | 622,914 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $1,114,749 | 586,710 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $750,640 | 568,667 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $582,393 | 570,974 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $146,041 | 79,804 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $98,956 | 79,804 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $90,976 | 79,804 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $73,020 | 79,804 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $44,690 | 79,804 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $76,377 | 132,370 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $41,828 | 132,370 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $342,467 | 476,974 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,003,345 | 443,958 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,278,599 | 443,958 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $4,177,372 | 1,102,209 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,435,551 | 1,014,934 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,676,825 | 956,009 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,365,363 | 942,376 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $14,217,227 | 1,046,924 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $5,628,998 | 742,612 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||